Xenon Pharmaceuticals Inc. (XENE) Social Stream

Xenon Pharmaceuticals Inc. (XENE): $26.00

-3.12 (-10.71%)

POWR Rating

Component Grades













Add XENE to Watchlist
Sign Up

Industry: Biotech


of 459

in industry

Xenon Pharmaceuticals Inc (XENE) Price Targets From Analysts

Use the tables below to see what analysts covering Xenon Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 8 $50 $40 $45.857 $29.12 57.48%
2021-10-28 8 $50 $34 $44.857 $29.12 54.04%

The Trend in the Analyst Price Target

Over the past 142 days, XENE's average price target has gone up $18.98.

Over the past 45 weeks, XENE's average upside potential has been 47.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 6 28 22 25.290 17.97 40.73%
2021-12-06 8 50 40 45.857 24.73 85.43%
2021-07-17 8 31 22 26.880 18.08 48.67%
2021-03-23 6 28 22 25.290 17.51 44.43%
2021-06-05 8 31 22 26.880 18.55 44.91%

XENE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 6 2 0 0 0 8

The Trend in the Broker Recommendations

XENE's average broker recommendation rating improved by 0 over the prior 61 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XENE as an investment opportunity.

  • Xenon Pharmaceuticals Inc's number of analysts covering the stock is higher than 187.2% of stocks in the small market cap category.
  • In terms of how Xenon Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 167.57% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Xenon Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 41.25% of them.
  • Xenon Pharmaceuticals Inc's variance in analysts' estimates is lower than 46.88% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, XBIT, WVE, and VYNE are the three stocks most similar to Xenon Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is XENE a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.772 seconds.